×
About 2,638 results

ALLMedicine™ Upper Respiratory Tract Infection Center

Research & Reviews  706 results

Comparison of clinical, pathological and long-term renal outcomes of children with Heno...
https://doi.org/10.1007/s11255-021-03063-7 10.1007/s00296-016-3425-3 10.1007/s00467-017-3597-4 10.1007/s11695-017-2940-y
International Urology and Nephrology; Torun Bayram M, Heybeli C et. al.

Dec 1st, 2021 - To compare clinical, pathological, and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis (HSPN) and IgA nephropathy (IgAN). The medical records of patients diagnosed as HSPN and IgAN during childhood were evaluated retro...

Dose tapering to withdrawal stage and long-term efficacy and safety of hetrombopag for ...
https://doi.org/10.1111/jth.15602
Journal of Thrombosis and Haemostasis : JTH; Mei H, Liu X et. al.

Nov 26th, 2021 - The efficacy of hetrombopag in Chinese patients with immune thrombocytopenia (ITP) has been demonstrated in a randomized, double-blind, placebo-controlled, multicenter, phase III trial (NCT03222843). This study aimed to report comprehensive data o...

Regulation divergences of Lactobacillus fermentum PCC and Lactobacillus paracasei 431 o...
https://doi.org/10.1039/d0fo02981e
Food & Function; Gao F, Fang Z et. al.

Nov 6th, 2021 - Antibiotic-induced host health imbalance during upper respiratory tract infection (URTI) treatment is an emerging issue. Studies have confirmed that Lactobacillus casei 431 and Lactobacillus fermentum PCC alleviate gut microbiome dysbiosis and imp...

Safety and tolerability of linagliptin in Asians with type 2 diabetes: a pooled analysi...
https://doi.org/10.1080/14740338.2022.1999409
Expert Opinion on Drug Safety; Kanasaki K, Qu S et. al.

Oct 30th, 2021 - Safety and tolerability of glucose-lowering drugs is a key consideration for use in type 2 diabetes (T2D). We evaluated the safety and tolerability of the dipeptidyl peptidase-4 inhibitor linagliptin in Asian patients with T2D. This was a post-hoc...

see more →

Guidelines  1 results

Clinical practice guideline for the diagnosis and management of acute bacterial sinusit...
https://doi.org/10.1542/peds.2013-1071
Pediatrics Wald ER, Applegate KE et. al.

Jun 26th, 2013 - To update the American Academy of Pediatrics clinical practice guideline regarding the diagnosis and management of acute bacterial sinusitis in children and adolescents. Analysis of the medical literature published since the last version of the gu...

see more →

Drugs  39 results see all →

Clinicaltrials.gov  44 results

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
https://clinicaltrials.gov/ct2/show/NCT04782687

Oct 27th, 2021 - Multiple myeloma (MM) is an incurable disease with high death rates as a result of developing resistance to treatments. Even with the advent of novel therapies, myeloma patients ultimately progress from frontline therapy. Common treatments include...

Comparison of the Anaesthetic Gases in Maintainance of General Anaesthesia in Paediatrics
https://clinicaltrials.gov/ct2/show/NCT04771962

Oct 21st, 2021 - Research design: Double blinded , randomised controlled trial. Involving paediatrics patients underwent elective surgeries requiring general anaesthesia in Hospital Universiti Sains Malaysia, Kubang Kerian. The duration of the study is 24 months. ...

COVID Vaccine Response in MS
https://clinicaltrials.gov/ct2/show/NCT05060354

Sep 29th, 2021 - Multiple sclerosis (MS) affects approximately 1 million persons in the United States and is the leading cause of disability in young adults. Disease modifying treatments for MS act through modulation or suppression of immune responses including B ...

Effect of Local Treatment(Carrageenan Nasal Spray and PVP-I Mouthwash) in Reducing Viral Load in Patients With COVID-19
https://clinicaltrials.gov/ct2/show/NCT05049213

Sep 27th, 2021 - Oral and nasal disinfection, a simple method with the application of commonly used antiseptic agents is frequently performed in the otolaryngology and dental practice. The ability to deactivate viral particles with a good safety profile may be an ...

The Effect of Synbiotics on the Upper Respiratory Tract Infection
https://clinicaltrials.gov/ct2/show/NCT04960878

Jul 14th, 2021 - Gut microbiome manipulation to alter the gut-lung axis may potentially protect humans against respiratory infections. However, clinical trials of synbiotics, one of the microbiota-targeted intervention, in this regard is few. Therefore, this study...

see more →

News  264 results

Novel Drug Sparks Hope for Targeting HER3 in NSCLC and Beyond
https://www.onclive.com/view/novel-drug-sparks-hope-for-targeting-her3-in-nsclc-and-beyond

Oct 11th, 2021 - Although oncogenic activation of the HER3 receptor has been identified as a significant source of drug resistance and treatment failure, efforts to develop therapies targeting this mechanism have so far fallen short.1 Now, patritumab deruxtecan, a...

ASH 2010: Brentuximab Vedotin Produces High Response Rate in Relapsed or Refractory Hodgkin Lymphoma
https://www.onclive.com/view/ash-2010-brentuximab-vedotin-produces-high-response-rate-in-relapsed-or-refractory-hodgkin-lymphoma

Oct 6th, 2021 - An investigational drug known as brentuximab vedotin (SGN-35) achieved dramatic responses in a pivotal phase II study involving younger patients with relapsed or refractory Hodgkin lymphoma (HL) who had no other treatment options, investigators re...

Fully Automated Capsule Endoscopy Feasible for Gastric Exams
https://www.medpagetoday.com/gastroenterology/generalgastroenterology/94677

Sep 23rd, 2021 - A fully automated magnetically controlled capsule endoscopy (FAMCE) was found to be comparable to conventional transoral gastroscopy for gastric examination and lesion detection in a prospective feasibility study conducted at two centers in China....

Zanubrutinib Responses Deepen Over Time in Relapsed/Refractory CLL
https://www.onclive.com/view/zanubrutinib-responses-deepen-over-time-in-relapsed-refractory-cll

Sep 20th, 2021 - Zanubrutinib (Brukinsa) monotherapy showed a deepening of response in patients with relapsed/refractory chronic lymphocytic leukemia (CLL), according to long-term follow-up of the phase 2 BGB-3111-205 trial (NCT03206918) that were presented at the...

FDA Approves First Twice-Yearly Antipsychotic for Schizophrenia
https://www.medscape.com/viewarticle/957972

Sep 1st, 2021 - The US Food and Drug Administration (FDA) has approved a 6-month injection form of the long-acting atypical antipsychotic paliperidone palmitate (Invega Hafyera, Janssen Pharmaceuticals) for the treatment of schizophrenia in adults, the company ha...

see more →

Patient Education  1 results see all →